2008
DOI: 10.2174/138955708785909899
|View full text |Cite
|
Sign up to set email alerts
|

Caspases: Structure-Guided Design of Drugs to Control Cell Death

Abstract: The structures of caspases reveal the mechanism of binding for non-peptide and protein inhibitors, and have been applied in the design of agents that either inhibit or activate caspases to control cell death in diverse diseases. Decreased cell death is desirable for treatment of stroke, nerve crush injury, myocardial infarction, neuromuscular and neurodegenerative diseases and several non-peptide caspase inhibitors have been developed. In contrast, activation of cell death would be advantageous in cancer thera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 64 publications
0
8
0
Order By: Relevance
“…Compound IDN-6556 is one such example [43]. Although the structure of its complex with caspase is not available, the aromatic moiety at its N terminus is likely to bind in the S4 of caspase-3 [44]. This oxamyl peptide compound showed inhibition of all caspases and is currently under phase II clinical trials in patients with liver transplants [45].…”
Section: Discussionmentioning
confidence: 99%
“…Compound IDN-6556 is one such example [43]. Although the structure of its complex with caspase is not available, the aromatic moiety at its N terminus is likely to bind in the S4 of caspase-3 [44]. This oxamyl peptide compound showed inhibition of all caspases and is currently under phase II clinical trials in patients with liver transplants [45].…”
Section: Discussionmentioning
confidence: 99%
“…Caspases belong to a family of highly conserved cysteine-dependent aspartate-specific acid proteases that use a cysteine residue as catalytic nucleophile and share a stringent specificity for cleaving their substrates after aspartic acid residues in target proteins [11]. They are synthesized as inert zymogens and upon receipt of apoptotic stimuli, cells activate initiator caspases such as, caspase-1, -2, -8, -9, and -10 that, in turn, proteolytically cleave and activate effector caspases including caspase-3, -6, and -7 [12]. Caspases have been further categorized as either proinflammatory or proapoptotic, depending upon their participation in these cellular responses.…”
Section: Introductionmentioning
confidence: 99%
“…Caspases have been further categorized as either proinflammatory or proapoptotic, depending upon their participation in these cellular programs. The proinflammatory caspases include caspase 1, 11 and 12 in mouse and caspase 1, 4, and 5 in human (16). Targeting caspase activity and apoptosis has gained significant attention for developing of novel therapeutic diagnostic strategies for NASH patients.…”
mentioning
confidence: 99%